Norges Bank’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-607,800
Closed -$7.76M 1774
2024
Q4
$7.76M Buy
+607,800
New +$7.35M ﹤0.01% 1399
2024
Q3
Sell
-236,400
Closed -$2.65M 1872
2024
Q2
$2.65M Buy
+236,400
New +$2.75M ﹤0.01% 1676
2022
Q2
Sell
-750,000
Closed -$8.13M 2088
2022
Q1
$8.13M Hold
750,000
﹤0.01% 1768
2021
Q4
$10.6M Buy
750,000
+311,700
+71% +$5.13M ﹤0.01% 1741
2021
Q3
$8.42M Buy
+438,300
New +$5.82M ﹤0.01% 1817

Other funds holding DVAX

Norges Bank's DVAX Position: Q1 2025 in Review

Norges Bank sold out of Dynavax Technologies (DVAX) in Q1 2025, closing a stake of 607,800 shares — an estimated $7.76M sold.

Norges Bank first reported a position in DVAX in Q3 2021 and held it in 5 quarters. The position peaked at $10.6M in Q4 2021. 284 funds tracked by Wall St. Rank hold DVAX as of Q1 2025.

  • Norges Bank reported no remaining Dynavax Technologies position as of Q1 2025 after selling out during the quarter.
  • Norges Bank sold 607,800 Dynavax Technologies shares in Q1 2025, an estimated $7.76M.
  • Norges Bank first reported a position in Dynavax Technologies in Q3 2021 and held it in 5 quarters.
  • Norges Bank's Dynavax Technologies position peaked at $10.6M in Q4 2021.
  • 284 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2025.

Based on Norges Bank's 13F filing for Q1 2025, filed 13 May 2025.